Borgess Medical Center/Borgess Research Institute

Kalamazoo, Michigan 49048

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed